Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPP-IV inhibitors for 24-hour glycemic variability in insulin-treated type 2 diabetes
ChiCTR-TRC-12001953Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoints: MODD, MAGE and 2 more. Started Mar 2012; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-12001953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001953.